Knut Engels

9.7k total citations · 1 hit paper
84 papers, 3.8k citations indexed

About

Knut Engels is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Knut Engels has authored 84 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 27 papers in Molecular Biology and 23 papers in Cancer Research. Recurrent topics in Knut Engels's work include Breast Cancer Treatment Studies (15 papers), HER2/EGFR in Cancer Research (10 papers) and Angiogenesis and VEGF in Cancer (7 papers). Knut Engels is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), HER2/EGFR in Cancer Research (10 papers) and Angiogenesis and VEGF in Cancer (7 papers). Knut Engels collaborates with scholars based in Germany, United Kingdom and United States. Knut Engels's co-authors include Christine Solbach, Gϋnter von Minckwitz, Thomas Karn, Uwe Holtrich, Sibylle Loibl, Achim Rody, Carsten Denkert, Claus Hanusch, Silvia Darb‐Esfahani and Ralf Kronenwett and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Knut Engels

83 papers receiving 3.8k citations

Hit Papers

Tumor-Associated Lymphocy... 2009 2026 2014 2020 2009 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
    2009 1.3k citations Carsten Denkert, Sibylle Loibl et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Knut Engels 2.1k 1.6k 926 908 462 84 3.8k
Anushka Dongre 1.8k 0.8× 2.0k 1.3× 764 0.8× 1.2k 1.3× 485 1.0× 15 3.8k
Sonja Loges 1.9k 0.9× 2.7k 1.8× 926 1.0× 1.4k 1.6× 630 1.4× 98 5.0k
Ruth Ganß 1.9k 0.9× 1.9k 1.2× 1.9k 2.1× 1.1k 1.2× 360 0.8× 58 4.5k
Sergio Palomo‐Ponce 2.3k 1.1× 1.9k 1.2× 854 0.9× 850 0.9× 534 1.2× 10 3.9k
Michele Moschetta 2.0k 1.0× 2.0k 1.3× 778 0.8× 675 0.7× 343 0.7× 96 4.2k
Cristina Nadal 2.3k 1.1× 2.2k 1.4× 475 0.5× 1.3k 1.4× 726 1.6× 42 4.3k
Hee Jin Lee 1.6k 0.8× 1.3k 0.8× 817 0.9× 1.0k 1.1× 453 1.0× 116 3.3k
Oddbjørn Straume 2.4k 1.1× 2.8k 1.8× 495 0.5× 1.3k 1.4× 694 1.5× 69 4.6k
Alexandre Calon 2.7k 1.3× 1.6k 1.0× 1.0k 1.1× 981 1.1× 508 1.1× 23 4.0k
Marta Sevillano 2.9k 1.4× 1.9k 1.2× 940 1.0× 1.0k 1.1× 495 1.1× 14 4.3k

Countries citing papers authored by Knut Engels

Since Specialization
Citations

This map shows the geographic impact of Knut Engels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Knut Engels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Knut Engels more than expected).

Fields of papers citing papers by Knut Engels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Knut Engels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Knut Engels. The network helps show where Knut Engels may publish in the future.

Co-authorship network of co-authors of Knut Engels

This figure shows the co-authorship network connecting the top 25 collaborators of Knut Engels. A scholar is included among the top collaborators of Knut Engels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Knut Engels. Knut Engels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leichsenring, Jonas, Christine Solbach, Thomas Karn, et al.. (2022). EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy. BMC Cancer. 22(1). 1040–1040.
2.
3.
Loibl, Sibylle, Karsten E. Weber, Jens Huober, et al.. (2018). Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular Predictor. Clinical Cancer Research. 24(14). 3358–3365. 8 indexed citations
4.
El‐Balat, Ahmed, Nicole Sänger, Thomas Karn, et al.. (2018). Claudin-1 is linked to presence of implants and micropapillary pattern in serous borderline epithelial tumours of the ovary. Journal of Clinical Pathology. 71(12). 1060–1064. 9 indexed citations
5.
6.
Villegas, Sonia L., Silvia Darb‐Esfahani, Gϋnter von Minckwitz, et al.. (2017). Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer. Breast Cancer Research and Treatment. 168(1). 179–187. 9 indexed citations
7.
El‐Balat, Ahmed, Ruža Arsenić, Nicole Sänger, et al.. (2015). Fascin-1 expression as stratification marker in borderline epithelial tumours of the ovary. Journal of Clinical Pathology. 69(2). 142–148. 7 indexed citations
8.
Sänger, Nicole, Eugen Ruckhäberle, Balázs Győrffy, et al.. (2014). Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer. Molecular Oncology. 9(1). 58–67. 32 indexed citations
9.
Sänger, Nicole, Knut Engels, Eugen Ruckhäberle, et al.. (2014). Molecular Markers as Prognostic Factors in DCIS and Small Invasive Breast Cancers. Geburtshilfe und Frauenheilkunde. 74(11). 1016–1022. 12 indexed citations
10.
Denkert, Carsten, Jens Huober, Sibylle Loibl, et al.. (2013). HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer. Breast Cancer Research. 15(1). R11–R11. 49 indexed citations
11.
Brieger, Angela, Knut Engels, Guido Plotz, et al.. (2011). Malignant fibrous histiocytoma is a rare Lynch syndrome-associated tumor in two German families. Familial Cancer. 10(3). 591–595. 16 indexed citations
12.
Ruckhäberle, Eugen, Thomas Karn, Lars Hanker, et al.. (2010). Breast Cancer Proteomics – Differences in Protein Expression between Estrogen Receptor-Positive and -Negative Tumors Identified by Tandem Mass Tag Technology. Breast Care. 5(1). 7–10. 5 indexed citations
13.
Trojan, Joerg, Renate Hammerstingl, Knut Engels, et al.. (2010). Contrast‐enhanced ultrasound in the diagnosis of malignant mesenchymal liver tumors. Journal of Clinical Ultrasound. 38(5). 227–231. 32 indexed citations
14.
Gross, Julia Christina, A. Schreiner, Knut Engels, & Anna Starzinski‐Powitz. (2009). E-cadherin Surface Levels in Epithelial Growth Factor-stimulated Cells Depend on Adherens Junction Protein Shrew-1. Molecular Biology of the Cell. 20(15). 3598–3607. 21 indexed citations
15.
Rody, Achim, Uwe Holtrich, L. Pusztai, et al.. (2009). T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers. Breast Cancer Research. 11(2). R15–R15. 336 indexed citations
16.
Engels, Knut, Shirley K. Knauer, Sibylle Loibl, et al.. (2008). NO Signaling Confers Cytoprotectivity through the Survivin Network in Ovarian Carcinomas. Cancer Research. 68(13). 5159–5166. 64 indexed citations
17.
Rody, Achim, Uwe Holtrich, R. Gaetje, et al.. (2007). Poor Outcome in Estrogen Receptor–Positive Breast Cancers Predicted by Loss of Plexin B1. Clinical Cancer Research. 13(4). 1115–1122. 54 indexed citations
18.
Stauber, Roland H., et al.. (2006). Nucleocytoplasmic Shuttling and the Biological Activity of Mouse Survivin are Regulated by an Active Nuclear Export Signal. Traffic. 7(11). 1461–1472. 35 indexed citations
19.
Diallo, Raihanatou, Achim Rody, Christian Jackisch, et al.. (2006). C-KIT expression in ductal carcinoma in situ of the breast: co-expression with HER-2/neu. Human Pathology. 37(2). 205–211. 20 indexed citations
20.
Engels, Knut, Stephen B. Fox, R Whitehouse, Kevin C. Gatter, & Adrian L. Harris. (1997). Up-regulation of thymidine phosphorylase expression is associated with a discrete pattern of angiogenesis in ductal carcinomasin situ of the breast. The Journal of Pathology. 182(4). 414–420. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anushka Dongre Breakdown of academic impact, for papers by Sonja Loges Breakdown of academic impact, for papers by Ruth Ganß Breakdown of academic impact, for papers by Sergio Palomo‐Ponce Breakdown of academic impact, for papers by Michele Moschetta Breakdown of academic impact, for papers by Cristina Nadal Breakdown of academic impact, for papers by Hee Jin Lee Breakdown of academic impact, for papers by Oddbjørn Straume Breakdown of academic impact, for papers by Alexandre Calon Breakdown of academic impact, for papers by Marta Sevillano
Rankless by CCL
2026